Literature DB >> 19461158

Novel mutation of aquaporin-2 gene in a patient with congenital nephrogenic diabetes insipidus.

Seong-Su Moon1, Han-Jong Kim, Yeon-Kyung Choi, Hyun-Ae Seo, Jae-Han Jeon, Jung-Eun Lee, Ju-Young Lee, Tae-Hwan Kwon, Jung-Guk Kim, Bo-Wan Kim, In-Kyu Lee.   

Abstract

Congenital nephrogenic diabetes insipidus (CNDI) is a rare inherited disease, characterized by an inability of the kidney to concentrate urine in response to vasopressin. Three different inheritance patterns have been described, i.e., the X-linked recessive form associated with arginine vasopressin V2 receptor (AVPR2) gene mutations, the autosomal recessive and dominant forms of CNDI associated with mutations in the aquaporin-2 (AQP2) gene encoding the vasopressin-regulated water channel of the renal collecting duct. Our case is an 18-year-old male patient who complained of severe polyuria since his infancy. But his developmental and growth status were normal. He was diagnosed as CNDI by water deprivation test and genomic DNA sequencing, which revealed high plasma AVP levels but persistently low urine osmolalities to 6 h-water deprivation and the novel missense mutation S216F in exon4 of the AQP2 gene. Immunohistochemistry of renal biopsied tissue revealed that most of the AQP2 labeling was seen intracellularly in a dotted pattern in the collecting duct principal cells. Immunoblotting of urine samples revealed significantly decreased urinary excretion of AQP2 (approximately 7% of normal control). Here, we report a new case of CNDI associated with the novel missense mutation of the AQP2 gene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19461158     DOI: 10.1507/endocrj.k09e-078

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  8 in total

Review 1.  Congenital nephrogenic diabetes insipidus: the current state of affairs.

Authors:  Daniel Wesche; Peter M T Deen; Nine V A M Knoers
Journal:  Pediatr Nephrol       Date:  2012-03-17       Impact factor: 3.714

2.  Congenital nephrogenic diabetes insipidus with a novel mutation in the aquaporin 2 gene.

Authors:  Youn Jong Park; Haing Woon Baik; Hae Il Cheong; Ju Hyung Kang
Journal:  Biomed Rep       Date:  2014-05-19

3.  Novel compound aquaporin 2 mutations in nephrogenic diabetes insipidus.

Authors:  Raphael D Liberatore Junior; Juliana G Carneiro; Franciele B Leidenz; Rachel Melilo-Carolino; Helena C Sarubi; Luiz De Marco
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

4.  Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus-update and epidemiology.

Authors:  Daniel G Bichet; Abdulah El Tarazi; Jessica Matar; Yoann Lussier; Marie-Françoise Arthus; Michèle Lonergan; Detlef Bockenhauer; Pierre Bissonnette
Journal:  Clin Kidney J       Date:  2012-03-28

5.  Effect of Glycyrrhiza on the Diuretic Function of Euphorbia kansui: An Ascites Mouse Model.

Authors:  Ya Lin; Yanqiong Zhang; Erxin Shang; Wenfang Lai; Hongwei Zhu; Yuhua Fang; Qingxia Qin; Haiyu Zhao; Na Lin
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-09       Impact factor: 2.629

6.  Severe congenital nephrogenic diabetes insipidus in a compound heterozygote with a new large deletion of the AQP2 gene. A case report.

Authors:  Ramón Peces; Rocío Mena; Carlos Peces; Fernando Santos-Simarro; Luis Fernández; Sara Afonso; Pablo Lapunzina; Rafael Selgas; Julián Nevado
Journal:  Mol Genet Genomic Med       Date:  2019-02-19       Impact factor: 2.183

7.  Further evidence for functional recovery of AQP2 mutations associated with nephrogenic diabetes insipidus.

Authors:  Pierre Bissonnette; Yoann Lussier; Jessica Matar; Alexandre Leduc-Nadeau; Sandra Da Cal; Marie-Françoise Arthus; Robert J Unwin; Julia Steinke; Dharshan Rangaswamy; Daniel G Bichet
Journal:  Physiol Rep       Date:  2021-06

Review 8.  AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.

Authors:  Chao Gao; Paul J Higgins; Wenzheng Zhang
Journal:  Cells       Date:  2020-09-26       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.